Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ·Healthcare·Biotechnology
$61.88
-1.17%
Mkt Cap $2.69B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$89.33
Range $68.00 – $100.00
Implied Upside
+44.4%
Consensus $89.33 vs current $61.88
NASDAQ·Healthcare·Biotechnology
$61.88
-1.17%
Mkt Cap $2.69B
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$89.33
Range $68.00 – $100.00
+44.4%
Consensus $89.33 vs current $61.88